Cr. Madden et al., Hepatitis B virus X protein acts as a tumor promoter in development of diethylnitrosamine-induced preneoplastic lesions, J VIROLOGY, 75(8), 2001, pp. 3851-3858
Chronic infection with hepatitis B virus (HBV) is one of the major etiologi
cal factors in the development of human hepatocellular carcinoma. Transgeni
c mice that express the HBV X protein (HBx) have previously been shown to b
e more sensitive to the effects of hepatocarcinogens. Although the mechanis
m for this cofactor role remains unknown, the ability of HBx to inhibit DNA
repair and to influence cell cycle progression suggests two possible pathw
ays. To investigate these possibilities in vivo, we treated double-transgen
ic mice that both express HBx (ATX mice) and possess a bacteriophage lambda
transgene with the hepatocarcinogen diethylnitrosamine (DEN). Histological
examination of liver tissue confirmed that DEN-treated ATX mice developed
approximately twice as many focal lesions of basophilic hepatocytes as trea
ted wild-type littermates. Treatment of mice with DEN resulted in a six- to
eightfold increase in the mutation frequency (MF), as measured by a functi
onal analysis of the lambda transgene. HBx expression was confirmed by immu
noprecipitation and Western blotting and was associated with a modest 23% i
ncrease in the MF. Importantly, the extent of hepatocellular proliferation
in 14-day-old mice, as measured by the detection of proliferating cell nucl
ear antigen and by the incorporation of 5-bromo-2'-deoxyuridine, was determ
ined to be approximately twofold higher in ATX livers than in wild-type liv
ers. These results are consistent,vith a model in which HBx expression cont
ributes to the development of DEN-mediated carcinogenesis by promoting the
proliferation of altered hepatocytes rather than by directly interfering wi
th the repair of DNA lesions.